Terumo (TRUMY) Stock Forecast & Price Target

$13.25 +0.20 (+1.53%)

As of 07/24/2026 03:59 PM Eastern

Compare

Terumo - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 2 Analyst Ratings

Sell
0

Hold
2

Buy
0

Based on 2 Wall Street analysts who have issued ratings for Terumo in the last 12 months, the stock has a consensus rating of "Hold." Out of the 2 analysts, 2 have given a hold rating for TRUMY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for TRUMY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Terumo and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRUMY Analyst Ratings Over Time

Type	Current Forecast 7/25/25 to 7/25/26	1 Month Ago 6/25/25 to 6/25/26	3 Months Ago 4/26/25 to 4/26/26	1 Year Ago 7/25/24 to 7/25/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	N/A
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Hold	Hold	Hold	N/A

TRUMY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TRUMY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Terumo Stock vs. The Competition

Type	Terumo	Medical Companies	Broader Market
Consensus Rating Score	2.00	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	N/A	974.23% Upside	14.30% Upside
News Sentiment Rating	Negative News See Recent TRUMY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside	Details
4/9/2026	Zacks Research Not Rated		Upgrade	Hold
2/24/2026	Nomura 4 of 5 stars		Upgrade	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:51 AM ET.

Should I Buy Terumo Stock? TRUMY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 22, 2026. Please send any questions or comments about these Terumo pros and cons to contact@marketbeat.com.

Terumo
Bull Case

Here are some ways that investors could benefit from investing in Terumo Co.:

The current stock price is around $17.97, which may present a buying opportunity for investors looking for value in the healthcare sector.
Recent short interest has shown a month-to-month increase, indicating that some investors are betting against the stock, which can create potential for a short squeeze if the company performs well.
With an average daily trading volume of approximately 219,500 shares, Terumo Co. offers liquidity, making it easier for investors to enter and exit positions.
The company has maintained a stable performance over the past year, with no significant fluctuations in its 52-week performance, suggesting a level of stability in its operations.
Institutional ownership is currently at 0%, which may indicate that the stock is undervalued and could attract institutional investors in the future, potentially driving up the stock price.

Terumo
Bear Case

Investors should be bearish about investing in Terumo Co. for these reasons:

The company has a very low short percentage of float, which may suggest a lack of confidence from investors regarding its growth potential.
Outstanding shares are reported as zero, which raises concerns about the company's market presence and ability to attract investment.
With no institutional ownership, there may be a lack of credibility and support from larger investors, which can impact stock performance negatively.
The recent increase in short interest, while potentially a buying opportunity, also indicates that some investors are skeptical about the company's future performance.
There has been no significant change in the company's financial metrics, which may suggest stagnation and a lack of growth prospects in a competitive market.

TRUMY Forecast - Frequently Asked Questions

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Terumo in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TRUMY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRUMY, but not buy additional shares or sell existing shares.

According to analysts, Terumo's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like Terumo less than other "medical" companies. The consensus rating score for Terumo is 2.00 while the average consensus rating score for "medical" companies is 2.29. Learn more on how TRUMY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Terumo Recommendations

This page (OTCMKTS:TRUMY) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Terumo (TRUMY) Stock Forecast & Price Target

Terumo - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

TRUMY Analyst Ratings Over Time

TRUMY Analyst Recommendations By Month

TRUMY Price Targets by Month

Terumo Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Terumo Stock? TRUMY Pros and Cons Explained

Terumo
Bull Case

Terumo
Bear Case

TRUMY Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Terumo Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Terumo (TRUMY) Stock Forecast & Price Target

Terumo - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

TRUMY Analyst Ratings Over Time

TRUMY Analyst Recommendations By Month

TRUMY Price Targets by Month

Terumo Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Terumo Stock? TRUMY Pros and Cons Explained

Terumo Bull Case

Terumo Bear Case

TRUMY Forecast - Frequently Asked Questions

Should I buy or sell Terumo stock right now?

Does Terumo's stock price have much downside?

Do Wall Street analysts like Terumo more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Terumo Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Terumo
Bull Case

Terumo
Bear Case